← Evidence map

ArticleAnnals of translational medicine2019

Erlotinib plus bevacizumab for

Helen Adderley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2019
2020
2021
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32016064